R. Rye

Antiestrogen Therapy Is Active in Selected Ovarian Cancer Cases: The Use of Letrozole in Estrogen Receptor–Positive Patients

H. Gabra, P. Vasey, J. Smyth, 2007, Clinical Cancer Research.

A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer.

C. Sturgeon, F. Balkwill, J. Smyth, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of tauromustine in malignant glioma.

A. Gregor, M. Aapro, I. Whittle, 1992, European journal of cancer.

The prognostic influence of bcl-2 in malignant glioma

A. Gregor, J. Ironside, H. Potts, 2002, British Journal of Cancer.

A clinical phase I and pharmacokinetic study of BBR 2778, a novel anthracenedione analogue, administered intravenously, 3 weekly.

J. Smyth, D. Jodrell, A. Bernareggi, 2000, European journal of cancer.

Phase I study of the novel anticancer drug PM00104 as a 24-hour IV infusion every 3 weeks (q3w) in patients (pts) with advanced solid tumors or lymphoma.

J. Baselga, J. Tabernero, J. Smyth, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Higher Incidence of Isolated Brain Metastases in Ovarian Cancer Patients With Previous Early Breast Cancer

J. Smyth, D. Faratian, C. Gourley, 2010, International Journal of Gynecologic Cancer.

A phase I study of the lipophilic thymidylate synthase inhibitor Thymitaq™ (nolatrexed dihydrochloride) given by 10-day oral administration

A. Boddy, A. Johnston, D. Jodrell, 1999, British Journal of Cancer.

Thymidylate Synthase

A. Boddy, A. Johnston, D. Jodrell, 2022 .